Harbour Investments’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Harbour Investments’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.5K	Buy	929 +93	+11%	+$3.24K	﹤0.01%	2589
2026 Q1	$28.7K	Hold	836	–	–	﹤0.01%	2658
2025 Q4	$27.5K	Hold	836	–	–	﹤0.01%	2268
2025 Q3	$23.8K	Hold	836	–	–	﹤0.01%	2249
2025 Q2	$21.4K	Hold	836	–	–	﹤0.01%	2196
2025 Q1	$23K	Hold	836	–	–	﹤0.01%	2133
2024 Q4	$22.5K	Hold	836	–	–	﹤0.01%	2072
2024 Q3	$24.1K	Hold	836	–	–	﹤0.01%	1973
2024 Q2	$22.8K	Hold	836	–	–	﹤0.01%	1896
2024 Q1	$23.4K	Hold	836	–	–	﹤0.01%	1887
2023 Q4	$22.3K	Hold	836	–	–	﹤0.01%	1831
2023 Q3	$21.4K	Hold	836	–	–	﹤0.01%	1718
2023 Q2	$21.9K	Hold	836	–	–	﹤0.01%	1728
2023 Q1	$21.8K	Hold	836	–	–	﹤0.01%	1706
2022 Q4	$22.9K	Sell	836 -69	-8%	-$1.84K	﹤0.01%	1620
2022 Q3	$24K	Hold	905	–	–	﹤0.01%	1560
2022 Q2	$24K	Buy	+905	New	+$23.9K	﹤0.01%	1560
2021 Q4	$23K	Hold	836	–	–	﹤0.01%	1604
2021 Q3	$22K	Hold	836	–	–	﹤0.01%	2244
2021 Q2	$22K	Hold	836	–	–	﹤0.01%	2291
2021 Q1	$21K	Buy	+836	New	+$21.9K	﹤0.01%	2182

Other funds holding FTXH

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

MIM

Marshall Investment Management Littleton, Colorado $241M AUM 30.53% 1-Year Est. Return

AIP

Ameritas Investment Partners Lincoln, Nebraska $3.75B AUM 46.53% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Harbour Investments's FTXH Position: Q2 2026 in Review

Harbour Investments increased its First Trust Nasdaq Pharmaceuticals ETF (FTXH) stake by 11% in Q2 2026, buying an estimated $3.24K and bringing the position to 929 shares worth $35.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2589.

Harbour Investments first reported a position in FTXH in Q1 2021 and has held it in 21 quarters since. 31 funds tracked by Wall St. Rank hold FTXH as of Q2 2026.

Harbour Investments held 929 shares of First Trust Nasdaq Pharmaceuticals ETF worth $35.5K as of Q2 2026.
Harbour Investments bought 93 First Trust Nasdaq Pharmaceuticals ETF shares in Q2 2026, an estimated $3.24K.
First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #2589 holding.
Harbour Investments first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q1 2021 and has held it in 21 quarters since.
31 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.